Venmax Drugs & Pharmaceuticals standalone net profit rises 1460.00% in the March 2025 quarter
09 - May - 2025 12:00 | 6 days ago
Net profit of Venmax Drugs & Pharmaceuticals rose 1460.00% to Rs 0.78 crore in the quarter ended March 2025 as against Rs 0.05 crore during the previous quarter ended March 2024. Sales reported to Rs 0.33 crore in the quarter ended March 2025. There were no Sales reported during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 0.01 crore in the year ended March 2025 as against net profit of Rs 0.06 crore during the previous year ended March 2024. Sales reported to Rs 0.81 crore in the year ended March 2025. There were no Sales reported during the previous year ended March 2024.
Venmax Drugs & Pharmaceuticals reports standalone net loss of Rs 0.50 crore in the December 2024 quarter
08 - Feb - 2025 12:00 | 96 days ago
Net loss of Venmax Drugs & Pharmaceuticals reported to Rs 0.50 crore in the quarter ended December 2024 as against net profit of Rs 0.03 crore during the previous quarter ended December 2023. Sales reported to Rs 0.20 crore in the quarter ended December 2024. There were no Sales reported during the previous quarter ended December 2023.
Venmax Drugs & Pharmaceuticals reports standalone net loss of Rs 0.50 crore in the December 2024 quarter
08 - Feb - 2025 12:00 | 96 days ago
Net loss of Venmax Drugs & Pharmaceuticals reported to Rs 0.50 crore in the quarter ended December 2024 as against net profit of Rs 0.03 crore during the previous quarter ended December 2023. Sales reported to Rs 0.20 crore in the quarter ended December 2024. There were no Sales reported during the previous quarter ended December 2023.
Venmax Drugs & Pharmaceuticals standalone net profit rises 1460.00% in the March 2025 quarter
09 - May - 2025 12:00 | 6 days ago
Net profit of Venmax Drugs & Pharmaceuticals rose 1460.00% to Rs 0.78 crore in the quarter ended March 2025 as against Rs 0.05 crore during the previous quarter ended March 2024. Sales reported to Rs 0.33 crore in the quarter ended March 2025. There were no Sales reported during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 0.01 crore in the year ended March 2025 as against net profit of Rs 0.06 crore during the previous year ended March 2024. Sales reported to Rs 0.81 crore in the year ended March 2025. There were no Sales reported during the previous year ended March 2024.
Venmax Drugs & Pharmaceuticals reports standalone net loss of Rs 0.50 crore in the December 2024 quarter
08 - Feb - 2025 12:00 | 96 days ago
Net loss of Venmax Drugs & Pharmaceuticals reported to Rs 0.50 crore in the quarter ended December 2024 as against net profit of Rs 0.03 crore during the previous quarter ended December 2023. Sales reported to Rs 0.20 crore in the quarter ended December 2024. There were no Sales reported during the previous quarter ended December 2023.
Venmax Drugs & Pharmaceuticals standalone net profit rises 1460.00% in the March 2025 quarter
09 - May - 2025 12:00 | 6 days ago
Net profit of Venmax Drugs & Pharmaceuticals rose 1460.00% to Rs 0.78 crore in the quarter ended March 2025 as against Rs 0.05 crore during the previous quarter ended March 2024. Sales reported to Rs 0.33 crore in the quarter ended March 2025. There were no Sales reported during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 0.01 crore in the year ended March 2025 as against net profit of Rs 0.06 crore during the previous year ended March 2024. Sales reported to Rs 0.81 crore in the year ended March 2025. There were no Sales reported during the previous year ended March 2024.
Venmax Drugs & Pharmaceuticals reports standalone net loss of Rs 0.50 crore in the December 2024 quarter
08 - Feb - 2025 12:00 | 96 days ago
Net loss of Venmax Drugs & Pharmaceuticals reported to Rs 0.50 crore in the quarter ended December 2024 as against net profit of Rs 0.03 crore during the previous quarter ended December 2023. Sales reported to Rs 0.20 crore in the quarter ended December 2024. There were no Sales reported during the previous quarter ended December 2023.
Venmax Drugs & Pharmaceuticals reports standalone net loss of Rs 0.50 crore in the December 2024 quarter
08 - Feb - 2025 12:00 | 96 days ago
Net loss of Venmax Drugs & Pharmaceuticals reported to Rs 0.50 crore in the quarter ended December 2024 as against net profit of Rs 0.03 crore during the previous quarter ended December 2023. Sales reported to Rs 0.20 crore in the quarter ended December 2024. There were no Sales reported during the previous quarter ended December 2023.
